Skip to Content

Is Belbuca a controlled substance?

Medically reviewed by Last updated on Nov 15, 2019.

Official Answer


Yes, Belbuca (generic name: buprenorphine) is an opioid (narcotic) medication that is in Controlled Substances Act schedule III, as determined by the Drug Enforcement Agency (DEA). Drugs in this schedule have a moderate potential for abuse; less than the drugs in schedules 1 and 2.

Belbuca is a buccal film used to treat pain that is severe enough to require daily, around-the-clock, long-term treatment with an opioid and for which other treatment option are inadequate. A buccal film is held in the buccal area (in the cheek) and the active ingredient buprenorphine absorbs and enters directly into the bloodstream.

Belbuca is not approved for the maintenance treatment of opioid dependence, unlike Suboxone, which is a sublingual (under the tongue) film containing buprenorphine and naloxone. Subutex, a sublingual tablet containing buprenorphine, was also approved for the treatment of opioid dependence but has since been discontinued.



Related Medical Questions

Drug Information

Related Support Groups